Ultragenyx Pharmaceutical (RARE) Other Non-Current Liabilities (2013 - 2026)
Ultragenyx Pharmaceutical (RARE) recorded Other Non-Current Liabilities of $1.13 billion in Q2 2026, up 43.9% from $782.75 million a year earlier but down 0.2% from the prior quarter.
Powered by 
Analysis
Ultragenyx Pharmaceutical (RARE) Other Non-Current Liabilities (2013 - 2026) Analysis & Trends
At the end of FY2025, Ultragenyx Pharmaceutical reported Other Non-Current Liabilities of $1.15 billion, up 39.9% from FY2024.
- Annual Other Non-Current Liabilities has a five-year compound annual growth rate of 27.9% (FY2020 to FY2025).
- Across earlier years, Other Non-Current Liabilities came in at $820 million in FY2024 (-4.9%), $862.33 million in FY2023 (-1.5%), $875.44 million in FY2022 (+148.9%) and $351.79 million in FY2021 (+4.8%).
- Quarterly Other Non-Current Liabilities has ranged from $348.07 million in Q3 2021 to $1.15 billion in Q4 2025 over the past five years.
- On a year-over-year basis, Other Non-Current Liabilities has increased for three consecutive quarters, with growth averaging 11.8% over the last eight quarters.
- Peak year-over-year performance for Other Non-Current Liabilities in the last five years was growth of 149.3% in Q1 2023, against a decline of 7.9% in Q3 2025 at the low end.
- Per Business Quant, the preceding three quarters came in at $1.13 billion (Q1 2026), $1.15 billion (Q4 2025) and $763.74 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn |
| 10 | Ultragenyx Pharmaceutical | 1.48 Bn | -321.29 Mn | 180.00 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.13 Bn |
| Mar 31, 2026 | 1.13 Bn |
| Dec 31, 2025 | 1.15 Bn |
| Sep 30, 2025 | 763.74 Mn |
| Jun 30, 2025 | 782.75 Mn |
| Mar 31, 2025 | 794.05 Mn |
| Dec 31, 2024 | 820.00 Mn |
| Sep 30, 2024 | 829.69 Mn |
| Jun 30, 2024 | 842.16 Mn |
| Mar 31, 2024 | 848.73 Mn |
| Dec 31, 2023 | 862.33 Mn |
| Sep 30, 2023 | 876.00 Mn |
| Jun 30, 2023 | 881.00 Mn |
| Mar 31, 2023 | 886.48 Mn |
| Dec 31, 2022 | 875.44 Mn |
| Sep 30, 2022 | 862.06 Mn |
| Jun 30, 2022 | 358.94 Mn |
| Mar 31, 2022 | 355.63 Mn |
| Dec 31, 2021 | 351.79 Mn |
| Sep 30, 2021 | 348.07 Mn |
API Access
Ultragenyx Pharmaceutical Other Non-Current Liabilities API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=other-non-current-liabilities&ticker=RARE&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "other-non-current-liabilities", "ticker": "RARE", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=other-non-current-liabilities&ticker=RARE&period=max&api_key=YOUR_API_KEY");
const data = await res.json();